Literature DB >> 35230693

Artificial Intelligence for Precision Oncology.

Sherry Bhalla1, Alessandro Laganà2.   

Abstract

Precision oncology is an innovative approach to cancer care in which diagnosis, prognosis, and treatment are informed by the individual patient's genetic and molecular profile. The rapid development of novel high-throughput omics technologies in recent years has led to the generation of massive amount of complex patient data, which in turn has prompted the development of novel computational infrastructures, platforms, and tools to store, retrieve, and analyze this data efficiently. Artificial intelligence (AI), and in particular its subfield of machine learning, is ideal for deciphering patterns in large datasets and offers unique opportunities for advancing precision oncology. In this chapter, we provide an overview of the various public data resources and applications of AI in precision oncology and cancer research, from subtype identification to drug prioritization, using multi-omics datasets. We also discuss the impact of AI-powered medical image analysis in oncology and present the first diagnostic FDA-approved AI-powered tools.
© 2022. Springer Nature Switzerland AG.

Entities:  

Keywords:  Artificial intelligence; Cancer; Cancer subtype; Deep learning; Drug prioritization; High-throughput technologies; Machine learning; Medical image analysis; Multi-omics; Precision oncology; Sequencing

Mesh:

Year:  2022        PMID: 35230693     DOI: 10.1007/978-3-030-91836-1_14

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  77 in total

Review 1.  Overview of Next-Generation Sequencing Technologies.

Authors:  Barton E Slatko; Andrew F Gardner; Frederick M Ausubel
Journal:  Curr Protoc Mol Biol       Date:  2018-04

Review 2.  Recent progress in mass spectrometry proteomics for biomedical research.

Authors:  Xu Li; Wenqi Wang; Junjie Chen
Journal:  Sci China Life Sci       Date:  2017-10-13       Impact factor: 6.038

3.  A Case for Data Commons: Toward Data Science as a Service.

Authors:  Robert L Grossman; Allison Heath; Mark Murphy; Maria Patterson; Walt Wells
Journal:  Comput Sci Eng       Date:  2016-08-24       Impact factor: 2.080

Review 4.  Epigenetics and Precision Oncology.

Authors:  Rachael J Werner; Andrew D Kelly; Jean-Pierre J Issa
Journal:  Cancer J       Date:  2017 Sep/Oct       Impact factor: 3.360

5.  A Description of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Common Data Analysis Pipeline.

Authors:  Paul A Rudnick; Sanford P Markey; Jeri Roth; Yuri Mirokhin; Xinjian Yan; Dmitrii V Tchekhovskoi; Nathan J Edwards; Ratna R Thangudu; Karen A Ketchum; Christopher R Kinsinger; Mehdi Mesri; Henry Rodriguez; Stephen E Stein
Journal:  J Proteome Res       Date:  2016-02-25       Impact factor: 4.466

Review 6.  The NCI Genomic Data Commons as an engine for precision medicine.

Authors:  Mark A Jensen; Vincent Ferretti; Robert L Grossman; Louis M Staudt
Journal:  Blood       Date:  2017-06-09       Impact factor: 22.113

7.  From the Broad Phase II Trial to Precision Oncology: A Perspective on the Origins of Basket and Umbrella Clinical Trial Designs in Cancer Drug Development.

Authors:  Deborah B Doroshow; James H Doroshow
Journal:  Cancer J       Date:  2019 Jul/Aug       Impact factor: 3.360

Review 8.  Specific targeted therapy of chronic myelogenous leukemia with imatinib.

Authors:  Michael W N Deininger; Brian J Druker
Journal:  Pharmacol Rev       Date:  2003-07-17       Impact factor: 25.468

9.  TCIA: An information resource to enable open science.

Authors:  Fred W Prior; Ken Clark; Paul Commean; John Freymann; Carl Jaffe; Justin Kirby; Stephen Moore; Kirk Smith; Lawrence Tarbox; Bruce Vendt; Guillermo Marquez
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2013

10.  Systematic identification of non-coding somatic single nucleotide variants associated with altered transcription and DNA methylation in adult and pediatric cancers.

Authors:  Fengju Chen; Yiqun Zhang; Chad J Creighton
Journal:  NAR Cancer       Date:  2021-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.